HOLX - Hologic, Inc.
NEXT EARNINGS:
Apr 30, 2026
EPS Est: $1.05
|
Rev Est: $1.0B
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$77.80
DETAILS
HIGH:
$79.00
LOW:
$76.00
MEDIAN:
$78.00
CONSENSUS:
$77.80
UPSIDE:
3.25%
Market Cap:
16.82B
Volume:
1,589,471
Avg Volume:
2,686,566
52 Week Range:
51.9-75.485
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
0.73
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
7,063
IPO Date:
1990-03-01
EPS (TTM):
2.50
P/E Ratio:
26.99
Revenue (TTM):
4.10B
Total Assets:
9.01B
Total Debt:
2.63B
Cash & Equiv:
1.96B
Rev Growth (5Y):
3.3%
EPS Growth (5Y):
8.7%
FCF Growth (5Y):
9.4%
ROCE:
9.0%
Debt/Equity:
0.52
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-29 | $1.04 | $1.09 | -4.6% | $1.0B | $1.0B | +0.9% |
| 2025-11-03 | $1.13 | $1.10 | +2.7% | $1.0B | $1.0B | +1.5% |
| 2025-07-30 | $1.08 | $1.05 | +2.9% | $1.0B | $1.0B | -1.0% |
| 2025-05-01 | $1.03 | $1.02 | +1.0% | $1.0B | $1.0B | +0.5% |
| 2025-02-05 | $1.03 | $1.02 | +1.0% | $1.0B | $1.0B | 0.0% |
| 2024-11-04 | $1.01 | $1.01 | 0.0% | $987.9M | $978.3M | +1.0% |
| 2024-07-29 | $1.06 | $1.02 | +3.9% | $1.0B | $1.0B | +1.0% |
| 2024-05-02 | $1.03 | $0.98 | +5.3% | $1.0B | $1.0B | +1.6% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.10B | 4.03B | 4.03B | 4.86B | 5.63B | 3.78B | 3.37B | 3.22B | 3.06B | 2.83B | 2.71B | 2.53B |
| Net Income | 565.70M | 789.50M | 456.00M | 1.30B | 1.87B | 1.12B | (40.20M) | (111.30M) | 755.50M | 330.80M | 131.60M | 17.30M |
| EPS | 2.50 | 3.35 | 1.85 | 5.18 | 7.28 | 4.24 | -0.15 | -0.40 | 2.70 | 1.18 | 0.47 | 0.06 |
| Total Assets | 9.01B | 9.16B | 9.14B | 9.07B | 8.92B | 7.20B | 6.61B | 7.23B | 7.98B | 7.32B | 7.67B | 8.41B |
| Total Debt | 2.63B | 2.66B | 2.90B | 2.92B | 3.14B | 3.15B | 3.11B | 3.36B | 3.38B | 3.38B | 3.65B | 4.30B |
| Cash & Equivalents | 1.96B | 2.16B | 2.72B | 2.34B | 1.17B | 701.00M | 601.80M | 666.70M | 540.60M | 548.40M | 492.70M | 741.60M |
| Operating Cash Flow | 1.06B | 1.29B | 1.05B | 2.13B | 2.33B | 896.60M | 649.50M | 732.90M | 8.30M | 787.20M | 786.10M | 508.40M |
| Free Cash Flow | 920.10M | 1.15B | 901.00M | 2.00B | 2.15B | 740.20M | 535.90M | 627.30M | (99.30M) | 688.70M | 696.70M | 428.20M |
| FCF per Share | 4.05 | 4.86 | 3.65 | 7.95 | 8.37 | 2.82 | 1.99 | 2.28 | -0.35 | 2.46 | 2.48 | 1.55 |
| Book Value | 5.05B | 5.13B | 5.02B | 4.88B | 4.22B | 2.71B | 2.28B | 2.43B | 2.78B | 2.14B | 2.08B | 2.06B |
| Cash & ST Investments | 2.20B | 2.33B | 2.72B | 2.34B | 1.17B | 701.00M | 601.80M | 666.70M | 540.60M | 548.40M | 492.70M | 741.60M |
| ROC Equity | 0.11 | 0.15 | 0.09 | 0.27 | 0.44 | 0.41 | -0.02 | -0.05 | 0.27 | 0.15 | 0.06 | 0.01 |